219 related articles for article (PubMed ID: 22914051)
1. Opposing roles for complement component C5a in tumor progression and the tumor microenvironment.
Gunn L; Ding C; Liu M; Ma Y; Qi C; Cai Y; Hu X; Aggarwal D; Zhang HG; Yan J
J Immunol; 2012 Sep; 189(6):2985-94. PubMed ID: 22914051
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.
Corrales L; Ajona D; Rafail S; Lasarte JJ; Riezu-Boj JI; Lambris JD; Rouzaut A; Pajares MJ; Montuenga LM; Pio R
J Immunol; 2012 Nov; 189(9):4674-83. PubMed ID: 23028051
[TBL] [Abstract][Full Text] [Related]
3. Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration.
Piao C; Cai L; Qiu S; Jia L; Song W; Du J
J Biol Chem; 2015 Apr; 290(17):10667-76. PubMed ID: 25739439
[TBL] [Abstract][Full Text] [Related]
4. Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.
Li B; Allendorf DJ; Hansen R; Marroquin J; Cramer DE; Harris CL; Yan J
Cancer Res; 2007 Aug; 67(15):7421-30. PubMed ID: 17671212
[TBL] [Abstract][Full Text] [Related]
5. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
6. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
[TBL] [Abstract][Full Text] [Related]
7. Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.
Coughlin B; Schnabolk G; Joseph K; Raikwar H; Kunchithapautham K; Johnson K; Moore K; Wang Y; Rohrer B
Sci Rep; 2016 Mar; 6():23794. PubMed ID: 27029558
[TBL] [Abstract][Full Text] [Related]
8. Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.
Barber A; Sentman CL
J Immunol; 2009 Aug; 183(4):2365-72. PubMed ID: 19625653
[TBL] [Abstract][Full Text] [Related]
9. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
10. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
Piao C; Zhang WM; Li TT; Zhang CC; Qiu S; Liu Y; Liu S; Jin M; Jia LX; Song WC; Du J
Exp Cell Res; 2018 May; 366(2):127-138. PubMed ID: 29551360
[TBL] [Abstract][Full Text] [Related]
11. Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNF-alpha and prostaglandin E2-dependent mechanisms.
Soruri A; Riggert J; Schlott T; Kiafard Z; Dettmer C; Zwirner J
J Immunol; 2003 Sep; 171(5):2631-6. PubMed ID: 12928416
[TBL] [Abstract][Full Text] [Related]
12. A Novel Role for C5a in B-1 Cell Homeostasis.
Bröker K; Figge J; Magnusen AF; Manz RA; Köhl J; Karsten CM
Front Immunol; 2018; 9():258. PubMed ID: 29520270
[TBL] [Abstract][Full Text] [Related]
13. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression.
Bak SP; Alonso A; Turk MJ; Berwin B
Mol Immunol; 2008 Dec; 46(2):258-68. PubMed ID: 18824264
[TBL] [Abstract][Full Text] [Related]
14. PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR/C5a axis from the tumor microenvironment.
Saito K; Iioka H; Maruyama S; Sumardika IW; Sakaguchi M; Kondo E
Neoplasia; 2019 Dec; 21(12):1121-1132. PubMed ID: 31759250
[TBL] [Abstract][Full Text] [Related]
15. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
16. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment.
Tsuji RF; Kawikova I; Ramabhadran R; Akahira-Azuma M; Taub D; Hugli TE; Gerard C; Askenase PW
J Immunol; 2000 Aug; 165(3):1588-98. PubMed ID: 10903768
[TBL] [Abstract][Full Text] [Related]
17. C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan.
Allendorf DJ; Yan J; Ross GD; Hansen RD; Baran JT; Subbarao K; Wang L; Haribabu B
J Immunol; 2005 Jun; 174(11):7050-6. PubMed ID: 15905548
[TBL] [Abstract][Full Text] [Related]
18. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.
Nunez-Cruz S; Gimotty PA; Guerra MW; Connolly DC; Wu YQ; DeAngelis RA; Lambris JD; Coukos G; Scholler N
Neoplasia; 2012 Nov; 14(11):994-1004. PubMed ID: 23226093
[TBL] [Abstract][Full Text] [Related]
19. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.
Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM
J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658
[TBL] [Abstract][Full Text] [Related]
20. Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
Fuenmayor J; Perez-Vazquez K; Perez-Witzke D; Penichet ML; Montano RF
Mol Cancer Ther; 2010 Aug; 9(8):2175-85. PubMed ID: 20682652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
